Science Weekly Science Weekly

Elizabeth Holmes is back in the spotlight: why can’t we look away?

Oct 22, 2026 · 17m

Summary

This episode examines the Theranos scandal and Elizabeth Holmes’s recent return to the spotlight via a new documentary. Host Madeleine Finlay and tech editor Blake Montgomery discuss how Holmes’s charismatic persona and Silicon Valley’s “fake it till you make it” culture allowed a fraudulent blood-testing company to reach a $9 billion valuation before crashing. The conversation explores the clash between slow scientific validation and rapid startup growth, noting that the lack of serious healthcare investors contributed to the fraud.

Topics discussed

Show intro Verizon Fios ad Whole Foods Market ad Theranos lab test ad Episode intro: Theranos and Elizabeth Holmes Origin story: Holmes and the rise of Theranos The collapse: Employee whistleblowing and fraud Why it lasted: Silicon Valley culture vs. healthcare Science vs. startup culture and lack of scrutiny Lessons learned? AI bubble and 'fake it till you make it' Billy Evans' new startup and consumer trust Promo: Radical Thinking with James Graham Thomson Reuters ad Impact on women in biotech and tech Why we are fascinated by Elizabeth Holmes Tech journalism accountability and future outlook Promo: NASA documentary Credits and sign-off Charles Schwab ad Verizon Fios ad (repeat) Thomson Reuters ad (repeat)

More from Science Weekly

Could measles and midterms bring down Maha?
Nov 19, 2026
Nasa’s Voyager 1 probe in sight of an incredible milestone
Nov 17, 2026
Is BMI working? Cop31 latest, the science of great conversation
Nov 12, 2026
Why we get Sad and what helps
Nov 10, 2026
‘Ferritin face’: can you really diagnose low iron from a selfie?
Nov 5, 2026
Listen ad-free on Castria